Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Cook

Showing results (601-610 of 623) with videos related to

Pageof 63
Sort By:
Transfusion|April 1, 1997
Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet lightL Lin, D N Cook, G P Wiesehahn, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2008
Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk)Kevin J Moriarty, Hidenori Takahashi, Steven S Pullen, et al.
Science (New York, N.Y.)|July 17, 2025
Controlled colonization of the human gut with a genetically engineered microbial therapeuticWeston R Whitaker, Zachary N Russ, Elizabeth Stanley Shepherd, et al.
Frontiers in Immunology|April 10, 2023
Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responsesSiân E Jossi, Melissa Arcuri, Areej Alshayea, et al.
Iscience|March 25, 2024
Erratum: Neurofilament light chain and vaccination status associate with clinical outcomes in severe COVID-19Young Erben, Mercedes Prudencio, Christopher P Marquez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 TrialBarbara H McGovern, Christopher B Ford, Matthew R Henn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMolly Olzinski, Yann Cobigo, Rowan Saloner, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Monoclonal nephritic factors reveal insights into C3 convertase dynamics and dysregulationSeth J Welsh, Christopher T Culek, Zhen Xu, et al.
Nature Communications|February 14, 2020
Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surfaceC Coral Domínguez-Medina, Marisol Pérez-Toledo, Anna E Schager, et al.
Nature Communications|January 4, 2019
Industrial scale high-throughput screening delivers multiple fast acting macrofilaricidesRachel H Clare, Catherine Bardelle, Paul Harper, et al.
Pageof 63

Showing results (601-610 of 623) with videos related to

Sort By:
Pageof 63
Transfusion|April 1, 1997
Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet lightL Lin, D N Cook, G P Wiesehahn, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2008
Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk)Kevin J Moriarty, Hidenori Takahashi, Steven S Pullen, et al.
Science (New York, N.Y.)|July 17, 2025
Controlled colonization of the human gut with a genetically engineered microbial therapeuticWeston R Whitaker, Zachary N Russ, Elizabeth Stanley Shepherd, et al.
Frontiers in Immunology|April 10, 2023
Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responsesSiân E Jossi, Melissa Arcuri, Areej Alshayea, et al.
Iscience|March 25, 2024
Erratum: Neurofilament light chain and vaccination status associate with clinical outcomes in severe COVID-19Young Erben, Mercedes Prudencio, Christopher P Marquez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 TrialBarbara H McGovern, Christopher B Ford, Matthew R Henn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMolly Olzinski, Yann Cobigo, Rowan Saloner, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Monoclonal nephritic factors reveal insights into C3 convertase dynamics and dysregulationSeth J Welsh, Christopher T Culek, Zhen Xu, et al.
Nature Communications|February 14, 2020
Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surfaceC Coral Domínguez-Medina, Marisol Pérez-Toledo, Anna E Schager, et al.
Nature Communications|January 4, 2019
Industrial scale high-throughput screening delivers multiple fast acting macrofilaricidesRachel H Clare, Catherine Bardelle, Paul Harper, et al.
Pageof 63